Response to: ‘Correspondence on ‘Preliminary predictive criteria for COVID-19 cytokine storm’’ by Tampeet al
Open Access
- 7 January 2021
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 82 (3), e72
- https://doi.org/10.1136/annrheumdis-2020-219720
Abstract
No abstract availableFunding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R56 AR072115-01 (to RC))
- Lupus Research Alliance (Target Identification in Lupus (to RC))
This publication has 7 references indexed in Scilit:
- Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'Annals Of The Rheumatic Diseases, 2023
- Tocilizumab in Patients Hospitalized with Covid-19 PneumoniaThe New England Journal of Medicine, 2021
- COVID-19 cytokine storm: what is in a name?Annals Of The Rheumatic Diseases, 2021
- Preliminary predictive criteria for COVID-19 cytokine stormAnnals Of The Rheumatic Diseases, 2021
- Tocilizumab for Covid-19-The Ongoing Search for Effective TherapiesThe New England Journal of Medicine, 2020
- Cytokine StormThe New England Journal of Medicine, 2020
- On the Alert for Cytokine Storm: Immunopathology in COVID‐19Arthritis & Rheumatology, 2020